4 terminated. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 4 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Drug Eruptions: new trials by email Literature Review of Drug Eruptions trials Research Report on Drug Eruptions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients Brimonidine Tartrate - Hand-foot Syndrome | Phase 2 | Terminated | Heinrich-Heine University, Duesseldorf | 2 | 2017-07-10 | 2019-01-09 |
| Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis Palifermin - Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome | Phase 1 / Phase 2 | Terminated | Brett King | 1 | 2010-10-01 | 2016-11-30 |
| Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer Nicotine patch - Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 2 | Terminated | University of California, San Francisco | 24 | 2007-08-20 | 2020-10-05 |
| Lamictal in the Treatment of Post-Herpetic Neuralgia Lamictal in the treatment of Post-Herpetic Neuralgia - Neuralgia, Postherpetic | Phase 2 / Phase 3 | Terminated | George Washington University | 2005-02-01 | 2013-03-13 |
Hand-Foot Syndrome (2) · Stevens-Johnson Syndrome (2) · Breast Neoplasms (1) · Neuralgia, Postherpetic (1)
Chemically-Induced Disorders (4) · Dermatitis (4) · Drug Hypersensitivity (4) · Drug-Related Side Effects and Adverse Reactions (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Erythema (2) · Erythema Multiforme (2) · Hypersensitivity (2) · Hypersensitivity, Delayed (2) · Immune System Diseases (2) · Mouth Diseases (2) · Skin Diseases, Vesiculobullous (2) · Stomatitis (2)
Brimonidine Tartrate (1) · Fibroblast Growth Factor 7 (1) · Lamotrigine (1) · Tobacco Use Cessation Devices (1)
Brett King (1) · George Washington University (1) · Heinrich-Heine University, Duesseldorf (1) · University of California, San Francisco (1)
United States (3) · Germany (1)
Hope S. Rugo, MD (1) · Perry K. Richardson, M.D. (1) · Peter Arne Gerber, PD Dr. med. (1)